CODEXIS, INC.

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

CDXS$1.11+2.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Revenues:
Product revenue	$6,807	$11,158	$20,246	$26,968
Research and development revenue	1,794	1,675	11,226	10,917
Total revenues	8,601	12,833	31,472	37,885
Costs and operating expenses:
Cost of product revenue	2,465	4,317	7,295	12,634
Research and development	13,868	11,505	40,586	34,164
Selling, general and administrative	11,217	13,568	35,889	42,100
Asset impairment and other charges	—	—	—	165
Total costs and operating expenses	27,550	29,390	83,770	89,063
Loss from operations	(18,949)	(16,557)	(52,298)	(51,178)
Interest income	634	849	1,969	2,730
Interest and other expense, net	(1,292)	(4,922)	(3,217)	(6,421)
Loss before income taxes	(19,607)	(20,630)	(53,546)	(54,869)
Provision for income taxes	8	10	29	31
Net loss	$(19,615)	$(20,640)	$(53,575)	$(54,900)
Net loss per share, basic and diluted	$(0.22)	$(0.29)	$(0.62)	$(0.78)
Weighted average common stock shares used in computing net loss per share, basic and diluted	90,251	72,032	86,045	70,759

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.